CMCR research was featured on PBS NOVA on September 29, 2021. As part of this update to the public on medicinal and recreational cannabis, NOVA reached out to Professor Doris Trauner, lead investigator in CMCR’s study on the possible efficacy of cannabidiol (CBD) in the management of symptoms of severe autism.
Current studies examine the effects of cannabis and cannabinoids on a range of psychiatric, developmental and pain conditions, as well as the impact of use on public safety (e.g., driving). A list of current and past studies can be found here.
Planning is currently underway for the CMCR Symposium for Spring 2022. Please check back for updates. Information on the CMCR symposium series, including archives of previous meetings, can be found here.